MitoCareX adds disease pathways to discovery platform
MitoCareX Bio is adding disease-pathway analysis to its existing tools. The company says early analyses are guiding development, but the new workflow has not yet been experimentally validated.
MitoCareX Bio is adding disease-pathway analysis to its existing tools. The company says early analyses are guiding development, but the new workflow has not yet been experimentally validated.